AIs may lack the cardioprotective and lipid lowering effects of tamoxifen but, in contrast to tamoxifen, do not increase the risk of serious life threatening thromboembolic or cerebrovascular events or endometrial cancer <a href=http://ciali.buzz>buy cialis</a> The most common ARs reported at a frequency 20 on the KISQALI arm and 2 higher than placebo were neutropenia, infections, leukopenia, cough, nausea, diarrhea, vomiting, constipation, pruritus, and rash